Association of biological age acceleration with muscle aging phenotype in young and middle-aged adults: a prospective cohort study.
- 15 July 2026
- journal article
- Published by Springer Nature in GeroScience
Abstract
Loss of muscle mass and quality (myopenia and myosteatosis) are hallmarks of aging and predictors of disability, yet their relationship with biological aging in younger adults is unclear. This prospective cohort study included 165,015 adults (mean age 39.9) who underwent low-dose chest computed tomography (CT) between 2010 and 2020. A longitudinal subset of 61,669 participants had repeated scans (median follow-up 4.1 years). We adopted blood-based Phenotypic Age acceleration (PhenoAgeAccel) and chest radiograph-based biological age acceleration (CXR-AgeAccel). Myopenia and myosteatosis were defined as muscle area and density values more than two standard deviations below young sex-specific reference means. Multivariable multinomial logistic and Cox proportional hazard models estimated associations between biological age acceleration and prevalent or incident muscle abnormalities, adjusting for sociodemographic, lifestyle, and clinical factors. PhenoAgeAccel was associated with higher odds of myopenia (OR 1.16, 95% CI 1.08-1.25), myosteatosis (OR 1.24, 95% CI 1.18-1.29), and combined myopenia-myosteatosis (OR 1.51, 95% CI 1.41-1.63). In longitudinal analyses, PhenoAgeAccel was associated with increased risk of incident myopenia (HR 1.21, 95% CI 1.08-1.35), myosteatosis (HR 1.18, 95% CI 1.09-1.28), and the combined myopenia-myosteatosis (HR 1.29, 95% CI 1.08-1.55). Associations were consistent, though attenuated, with CXR-AgeAccel (OR 1.34, 95% CI 1.20-1.50; HR 1.18, 95% CI 0.96-1.45). Associations persisted among participants < 40 years. Accelerated biological aging measured from routine blood and imaging data was associated with early deterioration in muscle mass and quality. Biological age may represent a practical marker for identifying individuals at risk of early musculoskeletal decline.Keywords
Funding Information
- National Research Foundation of Korea (RS-2024-00333941)
This publication has 60 references indexed in Scilit:
- Myopenia—a new universal term for muscle wastingJournal of Cachexia, Sarcopenia and Muscle, 2011
- Serum albumin concentration and heart failure riskAmerican Heart Journal, 2010
- Urinary creatinine excretion, an indirect measure of muscle mass, is an independent predictor of cardiovascular disease and mortality in the general populationAtherosclerosis, 2009
- Relation Between Alkaline Phosphatase, Serum Phosphate, and All-Cause or Cardiovascular MortalityCirculation, 2009
- Red Cell Distribution Width and Mortality in Older Adults: A Meta-analysisThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2009
- The developmental origins of sarcopeniaThe Journal of nutrition, health and aging, 2008
- White Blood Cell Count and Mortality in the Baltimore Longitudinal Study of AgingJACC, 2007
- Reduced physical activity increases intermuscular adipose tissue in healthy young adultsThe American Journal of Clinical Nutrition, 2007
- Effects of Aging on Muscle Fibre Type and SizeSports Medicine, 2004
- Low Relative Skeletal Muscle Mass (Sarcopenia) in Older Persons Is Associated with Functional Impairment and Physical DisabilityJournal of the American Geriatrics Society, 2002